Loading clinical trials...
Loading clinical trials...
This is a randomized, open-label, parallel-design study to be conducted at 75 centers within the United States. The study will be described to hemodialysis patients. Informed consent will be obtained ...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Genzyme, a Sanofi Company
NCT05398783 · Metabolic Disorders, Cancer, and more
NCT07547098 · Cardiovascular Diseases (CVD), Chronic Kidney Disease, and more
NCT07232537 · Chronic Kidney Disease, Type 2 Diabetes Mellitus
NCT05196035 · Chronic Kidney Disease, Proteinuria
NCT06721143 · Chronic Kidney Disease Stage 3
Gambro Healthcare-Gadsden
Gadsden, Alabama
nTouch Research
Huntsville, Alabama
Kidney Health Institute, LLC
Tucson, Arizona
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions